Skip to main content

Table 1 Baseline characteristics of study subjects

From: Body roundness index is a superior indicator to associate with the cardio‐metabolic risk: evidence from a cross‐sectional study with 17,000 Eastern-China adults

Variables

N

Number of cardio-metabolic abnormalities

P value

None

< 3

≥ 3

Sex, N (%)

    

< 0.001

 Male

7226

1785 (38.3 %)

4308 (43.3 %)

1133 (41.3 %)

 

 Female

10,134

2876 (61.7 %)

5650 (56.7 %)

1608 (58.7)

 

Age (years)

17,290

48.44 (14.88)

56.63 (14.11)

59.66 (12.57)

< 0.001

Smoker, N (%)

3575

923 (21.21 %)

2099 (22.35 %)

553 (21.63 %)

0.295

Alcohol drinker, N (%)

4191

1098 (26.94 %)

2438 (27.66 %)

655 (26.57 %)

0.471

Occupational labor strength, N (%)

    

< 0.001

 Mild

10,040

2444 (57.93 %)

5726 (62.73 %)

1870 (72.12 %)

 

 Moderate

3049

958 (22.71 %)

1754 (19.22 %)

337 (13.00 %)

 

 Heavy

2851

817 (19.36 %)

1648 (18.05 %)

386 (14.89 %)

 

Height (cm)

17,057

160.69 (7.95)

160.05 (8.33)

159.8 (8.57)

< 0.001

Weight (kg)

16,995

55.91 (8.67)

59.48 (10.29)

64.2 (10.75)

< 0.001

WC (cm)

17,018

75.11 (8.36)

80.27 (9.16)

85.8 (8.6)

< 0.001

HC (cm)

17,022

90.13 (6.09)

92.11 (6.71)

94.72 (6.7)

< 0.001

BMI (kg/m2)

16,967

21.62 (2.79)

23.15 (3.16)

25.06 (3.14)

< 0.001

WHR

17,004

0.83 (0.07)

0.87 (0.07)

0.91 (0.06)

< 0.001

WHtR

16,961

0.47 (0.05)

0.5 (0.06)

0.54 (0.05)

< 0.001

BAI

16,965

26.4 (3.95)

27.65 (4.15)

29.07 (4.29)

< 0.001

ABSI

16,878

0.08 (0.005)

0.08 (0.005)

0.08 (0.005)

< 0.001

BRI

16,961

2.83 (0.95)

3.47 (1.12)

4.15 (1.12)

< 0.001

ALT (U/L)

11,645

20.00 (13.92)

23.01 (16.79)

28.59 (20.66)

< 0.001

AST (U/L)

9354

24.99 (10.71)

27.45 (14.65)

29.85 (16.36)

< 0.001

Serum creatinine (umol/L)

9615

89.22 (12.80)

91.12 (16.81)

93.94 (17.71)

< 0.001

Blood urea nitrogen (mmol/L)

9358

5.6 (1.61)

5.86 (2.86)

5.71 (1.66)

< 0.001

SBP (mmHg)

17,359

112.52 (10.2)

133.94 (21.15)

146.58 (19.23)

< 0.001

DBP (mmHg)

17,359

68.97 (7.85)

79.01 (11.65)

84.64 (11.1)

< 0.001

FPG (mmol/L)

17,360

4.6 (0.48)

4.93 (1)

5.58 (1.52)

< 0.001

TG (mmol/L)

17,360

0.97 (0.32)

1.52 (1.04)

2.91 (2.04)

< 0.001

HDL–C(mmol/L)

17,360

1.62 (0.33)

1.5 (4.4)

1.16 (0.31)

< 0.001

LDL–C(mmol/L)

17,344

2.52 (0.73)

2.76 (0.79)

2.88 (0.84)

< 0.001

SUA (µmol/L)

17,360

280.96 (65.57)

315.93 (87.93)

377.27 (109.3)

< 0.001

Elevated BP

8578

0

6076 (61.0 %)

2502 (91.3 %)

< 0.001

Elevated FPG

2574

0

1374 (13.8 %)

1200 (43.8 %)

< 0.001

Elevated TG

5134

0

2793 (28.0 %)

2341 (85.4 %)

< 0.001

Reduced HDL-C

4506

0

2651 (26.6 %)

1855 (67.7 %)

< 0.001

Elevated SUA

2222

0

1196 (12.0 %)

1026 (37.4 %)

< 0.001

  1. Data are expressed as mean ± standard deviation or counts (percentages)
  2. WC waist circumference, HC hip circumference, BMI body mass index, WHR waist-to-hip ratio, WHtR waist-to-height ratio, BAI body adiposity index, ABSI a body shape index, BRI body roundness index, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, SUA serum uric acid, BP blood pressure, ALT alanine transaminase, AST aspartate transaminase